| 514 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
| 1 | DF | DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) {29} |
| 75 |  | .~ Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI {22} |
| 76 | DF | .~.~> Amine addition salt of organic phosphorus containing acid |
| 77 | DF | .~.~> Inner salt (e.g., betaine, etc.) {1} |
| 79 | DF | .~.~> Nitrogen containing hetero ring {6} |
| 95 | DF | .~.~> Sulfur containing hetero ring {3} |
| 99 | DF | .~.~> Oxygen containing hetero ring {2} |
| 102 | DF | .~.~> Two or more phosphorus atoms directly or indirectly bonded together by only covalent bonds {5} |
| 109 | DF | .~.~> P-X-X containing (X is chalcogen) |
| 110 | DF | .~.~> Phosphorus is part of a ring {1} |
| 112 | DF | .~.~> Cyano or isocyano containing {1} |
| 114 | DF | .~.~> Nitrogen, other than nitro or nitroso, bonded indirectly to phosphorus {4} |
| 120 | DF | .~.~> C=O other than as ketone or aldehyde, attached directly or indirectly to phosphorus {2} |
| 125 | DF | .~.~> Ketone or aldehyde containing |
| 126 | DF | .~.~> Sulfur not bonded directly to phosphorus {1} |
| 129 | DF | .~.~> Oxygen bonded directly to a carbon or hydrogen and wherein the oxygen is not bonded directly to phosphorus {1} |
| 131 | DF | .~.~> Nitro group bonded to a carbon {1} |
| 134 | DF | .~.~> Acyclic carbon to carbon unsaturation {2} |
| 137 | DF | .~.~> Nitrogen bonded directly to phosphorus {1} |
| 139 | DF | .~.~> Phosphorus bonded directly to halogen |
| 140 | DF | .~.~> (C)(R)P=X(-XC) containing (i.e., Phosphinate (X is chalcogen; R is C or H) |
| 141 | DF | .~.~> (CX-) (C)P=X(XH) or (CX-) (R)P=X(XC) containing (e.g., phosphonate, etc.) (X is chalcogen; R is C or H) |
| 142 | DF | .~.~> (CX-)(C)P(C),(CX-)(RX-)P(C),(CX-)P(XH)(XH) or (CX-)(CX-)P(-XR) containing (X is chalcogen; R is C or H) (e.g., phosphinite, phosphite, etc.) |
| 143 | DF | .~.~> Ester of (HX)P=X(XH)(XH) (X is chalcogen) (e.g., phosphate, etc.) {2} |